BioNTech SE (BNTX) Goodwill (2018 - 2025)

BioNTech SE has disclosed Goodwill across 8 years of filings, most recently posting $428.3 million for Q4 2025.

• Goodwill for Q4 2025 came in at $428.3 million, up 5.3% year-over-year; the trailing twelve-month figure through Dec 2025 was $428.3 million (up 5.3% YoY), and the FY2025 annual result was $415.7 million, up 2.2% from the prior year.
• Goodwill came in at $428.3 million for Q4 2025 at BioNTech SE, up from $418.2 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $428.3 million in Q4 2025 to a low of $62.4 million in Q4 2022.
• The 5-year median for Goodwill is $400.8 million (2024), against an average of $349.1 million.
• Across the five-year window, Goodwill declined 5.57% in 2022 and surged 524.65% in 2023, its largest moves.
• BioNTech SE's Goodwill stood at $66.1 million in 2021, then dropped by 5.57% to $62.4 million in 2022, then soared by 524.65% to $390.0 million in 2023, then grew by 4.28% to $406.7 million in 2024, then gained by 5.3% to $428.3 million in 2025.
• The last three Goodwill figures came in at $428.3 million (Q4 2025), $418.2 million (Q3 2025), and $412.1 million (Q2 2025), per Business Quant data.